Primary and secondary transcriptional effects in the developing human Down syndrome brain and heartReport as inadecuate




Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart - Download this document for free, or read online. Document in PDF available to download.

Genome Biology

, 6:R107

First Online: 16 December 2005Received: 26 July 2005Revised: 04 October 2005Accepted: 21 November 2005

Abstract

BackgroundDown syndrome, caused by trisomic chromosome 21, is the leading genetic cause of mental retardation. Recent studies demonstrated that dosage-dependent increases in chromosome 21 gene expression occur in trisomy 21. However, it is unclear whether the entire transcriptome is disrupted, or whether there is a more restricted increase in the expression of those genes assigned to chromosome 21. Also, the statistical significance of differentially expressed genes in human Down syndrome tissues has not been reported.

ResultsWe measured levels of transcripts in human fetal cerebellum and heart tissues using DNA microarrays and demonstrated a dosage-dependent increase in transcription across different tissue-cell types as a result of trisomy 21. Moreover, by having a larger sample size, combining the data from four different tissue and cell types, and using an ANOVA approach, we identified individual genes with significantly altered expression in trisomy 21, some of which showed this dysregulation in a tissue-specific manner. We validated our microarray data by over 5,600 quantitative real-time PCRs on 28 genes assigned to chromosome 21 and other chromosomes. Gene expression values from chromosome 21, but not from other chromosomes, accurately classified trisomy 21 from euploid samples. Our data also indicated functional groups that might be perturbed in trisomy 21.

ConclusionsIn Down syndrome, there is a primary transcriptional effect of disruption of chromosome 21 gene expression, without a pervasive secondary effect on the remaining transcriptome. The identification of dysregulated genes and pathways suggests molecular changes that may underlie the Down syndrome phenotypes.

Electronic supplementary materialThe online version of this article doi:10.1186-gb-2005-6-13-r107 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author:

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents